Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01786707 · ClinicalTrials.gov registry record · Phase 1
Autologous Stem Cell and Hyperbaric Oxygen Therapy in Type 2 Diabetes Mellitus
A Phase 1 study, sponsored by Rodolfo Alejandro.
- Completed
- Registry status
- Phase 1
- Development phase
- 2
- Enrollment target
NCT01786707 is a Phase 1 study that has completed, run by Rodolfo Alejandro. The registered enrollment target is 2 participants.
The verdict
NCT01786707, a Phase 1 study, has completed, sponsored by Rodolfo Alejandro.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 2 participants
- Enrollment target
Study Summary
A prospective, open labeled, randomized controlled clinical trial comparing the benefit of both hyperbaric oxygen therapy and intrapancreatic stem cell infusion to standard medical treatment alone for type 2 diabetes mellitus. Subjects will receive standard medical treatment (SMT) with insulin and metformin for 4 months (evaluation phase). Then they will be randomized into either the intervention group or the control group:
Interventions
- DRUG Metformin
- DRUG Insulin
- BIOLOGICAL Autologous stem cells
- OTHER Hyperbaric oxygen therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2009-07 |
| Est. Completion | 2013-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01786707
The ClinicalTrials.gov registry entry for NCT01786707 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rodolfo Alejandro, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Metformin is the first listed.
NCT01786707 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01786707 about?
NCT01786707 is a clinical study titled "Autologous Stem Cell and Hyperbaric Oxygen Therapy in Type 2 Diabetes Mellitus". A prospective, open labeled, randomized controlled clinical trial comparing the benefit of both hyperbaric oxygen therapy and intrapancreatic stem cell infusion to standard medical treatment alone for type 2 diabetes mellitus. Subjects will receive standard medical treatment (SMT) with insulin and m...
What is the current status of trial NCT01786707?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 2 participants. The study started on 2009-07. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01786707?
The interventions under investigation include: Metformin (DRUG), Insulin (DRUG), Autologous stem cells (BIOLOGICAL), Hyperbaric oxygen therapy (OTHER).
Who is sponsoring clinical trial NCT01786707?
This trial is sponsored by Rodolfo Alejandro, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.